tiprankstipranks
Trending News
More News >
Accelerate Diagnostics, Inc. (AXDXQ)
:AXDXQ
Advertisement

Accelerate Diagnostics (AXDXQ) Price & Analysis

Compare
310 Followers

AXDXQ Stock Chart & Stats


Ownership Overview

37.88%2.39%<0.01%59.73%
37.88%
Insiders
2.39%
Mutual Funds
<0.01% Other Institutional Investors
59.73% Public Companies and
Individual Investors

AXDXQ FAQ

What was Accelerate Diagnostics, Inc.’s price range in the past 12 months?
Accelerate Diagnostics, Inc. lowest stock price was <$0.01 and its highest was $2.09 in the past 12 months.
    What is Accelerate Diagnostics, Inc.’s market cap?
    Accelerate Diagnostics, Inc.’s market cap is $383.20K.
      When is Accelerate Diagnostics, Inc.’s upcoming earnings report date?
      Accelerate Diagnostics, Inc.’s upcoming earnings report date is Aug 07, 2025 which is in 12 days.
        How were Accelerate Diagnostics, Inc.’s earnings last quarter?
        Currently, no data Available
        Is Accelerate Diagnostics, Inc. overvalued?
        According to Wall Street analysts Accelerate Diagnostics, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Accelerate Diagnostics, Inc. pay dividends?
          Accelerate Diagnostics, Inc. does not currently pay dividends.
          What is Accelerate Diagnostics, Inc.’s EPS estimate?
          Accelerate Diagnostics, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Accelerate Diagnostics, Inc. have?
          Accelerate Diagnostics, Inc. has 25,210,392 shares outstanding.
            What happened to Accelerate Diagnostics, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Accelerate Diagnostics, Inc.?
            Currently, no hedge funds are holding shares in AXDXQ

            Company Description

            Accelerate Diagnostics, Inc.

            Accelerate Diagnostics, Inc. (AXDXQ) is a medical diagnostics company that specializes in the development and commercialization of innovative solutions aimed at rapidly identifying infectious pathogens and their susceptibility to antibiotics. Operating within the healthcare and biotechnology sectors, the company's core product offering includes the Accelerate Pheno system and Accelerate PhenoTest BC kit, which are designed to significantly reduce the time to result for blood culture testing, thereby improving patient outcomes and optimizing antibiotic therapy.
            Similar Stocks
            Company
            Price & Change
            Follow
            Cytosorbents
            Biomerica
            Co-Diagnostics
            Icecure Medical
            Bluejay Diagnostics
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis